A novel arm sleeve for upper extremity lymphedema: a pilot study

Area of Science:

• Medical Devices
• Lymphedema Management
• Compression Therapy

Background:

• Post-mastectomy upper extremity lymphedema is a common complication.
• Conventional arm sleeves may have limitations in coverage and effectiveness.
• Improving fluid drainage and venous return is crucial for managing lymphedema.

Purpose of the Study:

• To evaluate the safety and efficacy of a novel arm sleeve designed for extended body coverage.
• To compare the novel arm sleeve with a conventional arm sleeve in patients with upper extremity lymphedema.

Main Methods:

• A crossover study involving five subjects with post-mastectomy upper extremity lymphedema.
• Subjects used a conventional arm sleeve for two weeks, followed by the novel arm sleeve for two weeks.
• Assessments included adverse events, arm symptoms, interface pressures, and subcutaneous fluid distribution via MRI.

Main Results:

• The novel arm sleeve achieved graduated compression from forearm to shoulder (21.8 ± 3.7 mmHg to 8.8 ± 3.1 mmHg).
• Magnetic resonance imaging confirmed the novel sleeve avoided proximal fluid diffusion disturbance and venous occlusion.
• No adverse events or worsening of lymphedema symptoms were reported during the study.

Conclusions:

• The novel arm sleeve effectively provides graduated compression over a wider area, improving fluid and venous drainage.
• The extended coverage design successfully mitigated issues associated with conventional sleeves.
• The novel arm sleeve presents a safe and potentially superior therapeutic option for upper extremity lymphedema.